Cargando…
Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study
The adenosine antagonist 7-methylxanthine (7-mx) works against myopia in animal models. In a clinical trial, 68 myopic children (mean age 11.3 years) received either placebo or 7-mx tablets for 12 months. All participants subsequently received 7-mx for another 12 months, after which treatment was st...
Autores principales: | Trier, Klaus, Munk Ribel-Madsen, Søren, Cui, Dongmei, Brøgger Christensen, Søren |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802512/ https://www.ncbi.nlm.nih.gov/pubmed/20072638 http://dx.doi.org/10.1007/s12177-008-9013-3 |
Ejemplares similares
-
Effect of 7-methylxanthine on human retinal pigment epithelium cells cultured in vitro
por: Wan, Wenjuan, et al.
Publicado: (2017) -
Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes
por: Kothari, Mihir, et al.
Publicado: (2017) -
The Adenosine Receptor Antagonist, 7-Methylxanthine, Alters Emmetropizing Responses in Infant Macaques
por: Hung, Li-Fang, et al.
Publicado: (2018) -
Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence
por: Zhou, Lei, et al.
Publicado: (2023) -
The influence of axial myopia on optic disc characteristics of glaucoma eyes
por: Rezapour, Jasmin, et al.
Publicado: (2021)